ZUCCHINI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 4.707
EU - Europa 1.916
AS - Asia 851
OC - Oceania 3
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.483
Nazione #
US - Stati Uniti d'America 4.693
PL - Polonia 632
CN - Cina 469
RU - Federazione Russa 340
UA - Ucraina 267
IT - Italia 202
DE - Germania 172
TR - Turchia 165
SG - Singapore 163
GB - Regno Unito 135
FI - Finlandia 61
SE - Svezia 33
ID - Indonesia 26
CZ - Repubblica Ceca 25
FR - Francia 16
AT - Austria 14
CA - Canada 13
VN - Vietnam 10
BE - Belgio 8
IR - Iran 7
PT - Portogallo 4
IN - India 3
AU - Australia 2
BG - Bulgaria 2
BR - Brasile 2
DK - Danimarca 2
KR - Corea 2
PK - Pakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
EG - Egitto 1
IE - Irlanda 1
JP - Giappone 1
LB - Libano 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 7.483
Città #
Fairfield 683
Woodbridge 645
Warsaw 632
Houston 378
Ashburn 370
Chandler 350
Jacksonville 312
Ann Arbor 256
Seattle 256
Wilmington 243
Cambridge 198
Beijing 142
Singapore 119
Nanjing 106
Izmir 102
Ferrara 84
Princeton 71
New York 58
San Diego 56
Shanghai 53
Milan 48
Boardman 39
Washington 34
Munich 32
Los Angeles 27
Jakarta 26
Nanchang 25
Santa Clara 22
Hebei 21
Brno 18
Jiaxing 17
Norwalk 16
Shenyang 16
Auburn Hills 14
Vienna 14
Dearborn 13
Falls Church 13
Mcallen 13
Montréal 12
Tianjin 12
Bremen 11
Mountain View 11
Changsha 10
Bologna 9
San Mateo 9
Dong Ket 8
Ningbo 8
Redwood City 8
Ardabil 7
Brussels 7
Jinan 7
Kunming 7
Olomouc 7
Hangzhou 6
Zhengzhou 6
Guangzhou 5
Arezzo 4
Augusta 4
Helsinki 4
Philadelphia 4
Phoenix 4
Taizhou 4
Changchun 3
Ferrara di Monte Baldo 3
Indiana 3
Lanzhou 3
Leawood 3
Monmouth Junction 3
Orange 3
Pieve Emanuele 3
Pisa 3
Redmond 3
Serpa 3
Verona 3
Addison 2
Chiswick 2
Des Moines 2
Hounslow 2
Kilburn 2
Lappeenranta 2
London 2
Molinella 2
Pescara 2
Pune 2
San Jose 2
Sofia 2
Auckland 1
Belgrade 1
Cagliari 1
Calderara Di Reno 1
Carros 1
Castelfranco Emilia 1
Chuxiong 1
Cotriguacu 1
Cuauhtémoc 1
Doncaster 1
Dublin 1
Dueville 1
Eden Prairie 1
Edmonton 1
Totale 5.770
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 444
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 307
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 290
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 264
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 257
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 160
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 139
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 136
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 134
Personalized needles for microinjections in the rodent brain 126
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 122
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 122
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 122
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 122
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 121
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 121
A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb 117
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 116
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 116
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 115
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 114
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 113
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 113
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 112
Involvement of the neuropeptide Orphanin FQ/Nociceptin in kainate and kindling seizures and epileptogenesis. 111
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 111
null 111
Mechanisms of action of CHF3381 in the forebrain 109
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 109
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 108
Fibroblast Growth Factor-2 (FGF-2). 107
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 104
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 102
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 101
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 98
null 97
Gene Therapy Tools for Brain Diseases 97
null 94
null 94
null 93
null 92
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 91
HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) URACIL-DNA GLYCOSYLASE - FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI, BIOCHEMICAL-CHARACTERIZATION, AND SELECTIVE-INHIBITION BY 6-(P-N-OCTYLANILINO)URACIL 90
null 89
null 89
null 89
Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: New evidence from rats and mice 87
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 87
Temporal lobe epilepsy model, neural stem cells and gene therapy 86
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 78
Properties and maturation of adult-generated dopaminergic neurons in the mammalian olfactory bulb 75
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 69
Different patterns of induction of FGF-2 and BDNF mRNAs during kindling epileptogenesis, and development of a herpes simplex vector for FGF-2 gene transfer in vivo. 69
Increased susceptibility to kainate seizures and decreased seizure-induced cell loss in transgenic mice overexpressing fibroblast growth factor-2 68
Dynorphin and Nociceptin/Orphanin FQ (N/OFQ). 68
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 68
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 63
Implication of sestrin3 in epilepsy and its comorbidities 59
Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis 58
Gene therapy of the nervous system by herpes virus vectors 57
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 55
null 43
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 39
Molecular approaches to inhibit HIV-1 tat expression and functions 38
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 38
Impairment of GABA release in the hippocampus at the time of the first spontaneous seizure in the pilocarpine model of temporal lobe epilepsy 30
Low-dose 7,8-Dihydroxyflavone Administration After Status Epilepticus Prevents Epilepsy Development 28
Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson’s disease 28
Increased extracellular levels of glutamate in the hippocampus of chronically epileptic rats 28
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 28
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 25
Possible Approaches of Gene Therapy of AIDS. 20
Increased excitability in tat-transgenic mice: role of tat in HIV-related neurological disorders 19
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist 17
Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats during EEG Recordings 16
Implication of fibroblast growth factors in epileptogenesis-associated circuit rearrangements. 15
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 14
Viral Vector-Based Gene Therapy for Epilepsy: What Does the Future Hold? 12
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 11
The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models 11
Totale 7.596
Categoria #
all - tutte 30.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.345
Totale 31.725


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.439 0 0 88 230 127 185 140 172 137 172 137 51
2020/20211.016 85 115 55 99 53 100 43 113 38 157 113 45
2021/2022742 31 94 61 24 27 28 47 42 20 48 69 251
2022/2023749 75 46 48 80 120 102 39 77 103 4 40 15
2023/2024891 42 46 42 12 50 226 89 97 66 63 50 108
2024/2025251 56 47 148 0 0 0 0 0 0 0 0 0
Totale 7.596